Related Experiment Videos
The immunoregulatory disturbance in autoimmune thyroid disease
1Department of Medicine, Wellesley Hospital, University of Toronto, Ontario, Canada.
Autoimmunity
|January 1, 1988
Summary
Autoimmune thyroid disease (AITD) stems from a genetic defect in suppressor T lymphocytes. Environmental factors and hyperthyroidism can worsen this, impacting generalized T-cell function and disease expression.
Area of Science:
- Immunology
- Endocrinology
- Genetics
Background:
- Autoimmune thyroid disease (AITD) is characterized by immune system dysfunction targeting the thyroid.
- Evidence suggests a genetically determined, antigen-specific defect in suppressor T lymphocytes underlies AITD.
- Environmental factors and hyperthyroidism may exacerbate AITD by affecting generalized suppressor T lymphocyte function.
Purpose of the Study:
- To elucidate the underlying mechanisms of autoimmune thyroid disease (AITD).
- To investigate the interplay between genetic predisposition, environmental factors, and immune system dysregulation in AITD pathogenesis.
- To understand the role of suppressor T lymphocytes and HLA-DR expression in AITD, including Graves' disease.
Main Methods:
- Review and synthesis of evidence from multiple laboratories and experimental techniques.
- Analysis of T lymphocyte function and numbers in the context of AITD.
- Examination of antigen presentation by thyroid cells and the role of interferon gamma.
Main Results:
- A genetically induced, antigen-specific defect in suppressor T lymphocytes is a primary basis for AITD.
- Environmental factors and hyperthyroidism can additively reduce generalized suppressor T lymphocyte function, potentially precipitating and perpetuating disease.
- Thyroid cell HLA-DR expression, driven by T-lymphocyte interferon gamma, appears to be an amplifying factor, not the primary inductive step.
Conclusions:
- The initiating event in human AITD likely involves perturbation of the generalized immune system superimposed on an organ-specific defect.
- Disease expression varies based on the severity of the suppressor T lymphocyte defect and environmental influences.
- Remissions in Graves' disease with antithyroid drugs may result from reduced thyrocyte-immunocyte signaling in individuals with partial defects.